As per Technavio's Research Analysis, the smoking cessation and nicotine de-addiction market is likely to register a CAGR of over 13% while registering an incremental growth of USD 16.6 billion during 2020-2024.
Technavio reports offer customer landscape matrix and vendor landscape analysis that assists global businesses to obtain growth opportunities Download Free Sample Now!
With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
The recovery process involves various phases including:-
Recognizing the existing business model
Build Resilience by making effective resource and investment choices for individual business units, products, and service lines.
Assessing Impact on Critical IT infrastructure and Software System
Key Considerations for Market Forecast:
Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
Pre- as well as post-COVID-19 market estimates
Quarterly impact analysis and updates on market estimates
Gain instant access to 17,000+ market research reports by using
British American Tobacco Plc offers smoking cessation products such as vapor products; traditional oral products, including moist snuff and snus; and modern oral products, including tobacco-free nicotine pouches.
Cipla Ltd. offers smoking cessation products through the Nicotex brand.
Pfizer Inc. offers Nicotrol Inhaler, a nicotine inhalation system that consists of a mouthpiece and a plastic cartridge.
Smoking Cessation And Nicotine De-Addiction Market 2020-2024: Segmentation
The smoking cessation and nicotine de-addiction market are segmented as below:
The smoking cessation and nicotine de-addiction market is driven by the growing number of people trying to quit smoking. In addition, the product innovations are expected to trigger the smoking cessation and nicotine de-addiction market toward witnessing a CAGR of over 13% during the forecast period.
Global Biosimilars Market- The biosimilars market is segmented by application (oncology and hematology, immunology, endocrinology, and nephrology) and geography (Europe, Asia, North America, and ROW). Download FREE Sample Report
Global Chronic Obstructive Pulmonary Disease Drugs Market- The chronic obstructive pulmonary disease drugs market is segmented by product (combination therapy and monotherapy) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.